Harnessing Nanomedicine to Combat Hepatic Fibrosis
Understanding nanomedicinesNanomedicine in hepatic fibrosis diagnosisNanomedicine in hepatic fibrosis treatmentNanomedicine in drug delivery Nanomedicine in targeted drug delivery Future perspectivesReferencesFurther reading Hepatic fibrosis is an abnormal wound-healing response triggered by chronic liver diseases, including non-alcoholic fatty liver disease, viral or alcoholic hepatitis, and Wilson’s disease. The response is characterized by excessive synthesis and deposition of extracellular matrix (ECM) components, which […]
Continue reading »